UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB Number:  3235-0578

 

Expires:    April 30, 2013

 

Estimated average burden hours per response......5.6

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Life Sciences Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617 772-8500

 

 

Date of fiscal year end:  September 30

 

 

Date of reporting period:  7/1/09-6/30/10

 

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

HQL N-PX for the period July 1, 2009 to June 30, 2010

 

CUSIP

 

Symbol

Company Name

 

 

00484M106

 

ACOR

Acorda Therapeutics, Inc

 

 

Meeting Date:

6/9/2010

 

Meeting Type:

Annual

Record Date:

4/14/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director John P. Kelley

 

For

 

Yes

 

For

 

Management

1

 

Elect director Sandra Panem, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Wise Young

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of Ernst & Young LLP as the company’s independent auditors for the fiscal year ending December 31, 2010.

 

For

 

Yes

 

For

 

Management

 

00724X102

 

ADLR

Adolor Corporation

 

 

Meeting Date:

5/18/2010

 

Meeting Type:

Annual

Record Date:

3/22/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Paul Goddard, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Claude H. Nash, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Donald Nickelson

 

For

 

Yes

 

For

 

Management

2

 

Ratification of appointment of KPMG LLP as independent registered public accountants for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

00817Y108

 

AET

Aetna Inc.

 

 

Meeting Date:

5/21/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Frank M. Clark

 

For

 

Yes

 

For

 

Management

1

 

Elect director Betsy Z. Cohen

 

For

 

Yes

 

For

 

Management

1

 

Elect director Molly J. Coye, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Roger N. Farah

 

For

 

Yes

 

For

 

Management

1

 

Elect director Barbara Hackman Franklin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jeffrey E. Garten

 

For

 

Yes

 

For

 

Management

1

 

Elect director Earl G. Graves

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gerald Greenwald

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ellen M. Hancock

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard J. Harrington

 

For

 

Yes

 

For

 

Management

1

 

Elect director Edward J. Ludwig

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph P. Newhouse

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ronald A. Williams

 

For

 

Yes

 

For

 

Management

2

 

Approval of independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

3

 

Approval of Aetna Inc. 2010 stock incentive Plan

 

For

 

Yes

 

For

 

Management

4

 

Approval of Aetna Inc. 2010 non-employee director compensation plan

 

For

 

Yes

 

For

 

Management

5

 

Approval of Aetna Inc. 2010 annual incentive plan performance criteria

 

For

 

Yes

 

For

 

Management

6

 

Shareholder proposal on cumulative voting

 

Against

 

Yes

 

Against

 

Stockholder

7

 

Shareholder proposal on independent chairman

 

Against

 

Yes

 

For

 

Stockholder

 

1


 

00826A109

 

AFFY

Affymax, Inc.

 

 

Meeting Date:

5/24/2010

 

Meeting Type:

Annual

Record Date:

3/31/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Kathleen Laporte

 

For

 

Yes

 

For

 

Management

1

 

Elect director Keith R. Leonard

 

For

 

Yes

 

For

 

Management

1

 

Elect director Christi Van Heek

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of Affymax for its fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

9728106

 

AKRX

Akorn Inc

 

 

Meeting Date:

8/7/2009

 

Meeting Type:

Annual

Record Date:

6/15/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To re-elect John N. Kappor, PH.D

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Jerry N. Ellis

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Ronald M. Johnson

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Subhash Kapre, PH. D

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Brian Tambi

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Steven J. Meyer

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Alan Weinstein

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Randall J. Wall

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the selection of Ernst & Young LLP to serve as Akorn’s independent registered public accounting firm for the fiscal year ending December 31, 2009.

 

For

 

Yes

 

For

 

Management

3

 

Approval of an amendment to the company’s 2003 amended and restated stock option plan to increase the total number of shares authorized and reserved for inssuance by 6,000,000 shares.

 

For

 

Yes

 

For

 

Management

4

 

Approval of an amendment to the company’s amended and restated employee stock purchase plan to increase the total number of shares authorized and reserved for inssuance by 1,000,000 shares.

 

For

 

Yes

 

For

 

Management

 

2


 

9728106

 

AKRX

Akorn Inc

 

 

Meeting Date:

5/21/2010

 

Meeting Type:

Annual

Record Date:

4/7/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To re-elect John N. Kappor, PH.D

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Ronald M. Johnson

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Brian Tambi

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Steven J. Meyer

 

For

 

Yes

 

For

 

Management

1

 

To re-elect Alan Weinstein

 

For

 

Yes

 

For

 

Management

1

 

To elect Kenneth S. Abraowitz

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the selection of Ernst & Young LLP to serve as Akorn’s independent registered public accounting firm for the fiscal year ending December 31, 2010.

 

For

 

Yes

 

For

 

Management

3

 

Approval of the grant of non-qualified stock options to Akorn’s interim Chief Executive Officer, Rajat Rai

 

For

 

Yes

 

For

 

Management

 

015351109

 

ALXN

Alexion Pharmaceuticals, Inc.

 

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/17/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Leonard Bell

 

For

 

Yes

 

For

 

Management

1

 

Elect director Max Link

 

For

 

Yes

 

For

 

Management

1

 

Elect director William R. Keller

 

 

 

 

 

 

 

 

1

 

Elect director Joseph A. Madri

 

For

 

Yes

 

For

 

Management

1

 

Elect director Larry L. Mathis

 

For

 

Yes

 

For

 

Management

1

 

Elect director R. Douglas Norby

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alvin S. Parven

 

For

 

Yes

 

For

 

Management

1

 

Elect director Andreas Rummelt

 

For

 

Yes

 

For

 

Management

2

 

Approval of the Amendment to 2004 incentive plan, as described in the accompanying proxy statement, including to increase the number of shares of common stock available for issuance by 3 million shares (subject to adjustment in the event of stock splits and other similar events)

 

For

 

Yes

 

For

 

Management

3

 

Ratification of appointment by the board of directors of PricewaterhouseCoopers LLP as Alexion’s independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

3


 

016255101

 

ALGN

Align Technology, Inc.

 

 

Meeting Date:

5/20/2010

 

Meeting Type:

Annual

Record Date:

3/23/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director David E. Collins

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph Lacob

 

For

 

Yes

 

For

 

Management

1

 

Elect director C. Raymond Larkin, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director George J. Morrow

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dr. David Nagel

 

For

 

Yes

 

For

 

Management

1

 

Elect director Thomas M. Prescott

 

For

 

Yes

 

For

 

Management

1

 

Elect director Greg J. Santora

 

For

 

Yes

 

For

 

Management

1

 

Elect director Warren S. Thaler

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.’s independent registered public accountants for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

3

 

Proposal to approve amended and restated 2005 equity incentive plan

 

For

 

Yes

 

For

 

Management

4

 

Proposal to approve 2010 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

 

01642T108

 

ALKS

Alkermes, Inc.

 

 

Meeting Date:

10/6/2009

 

Meeting Type:

Annual

Record Date:

7/24/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director David W. Anstice

 

For

 

Yes

 

For

 

Management

1

 

Elect director Floyd E. Bloom

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert A. Breyer

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dvid A. Broeckert

 

For

 

Yes

 

For

 

Management

1

 

Elect director Geraldine Henwood

 

For

 

Yes

 

For

 

Management

1

 

Elect director Paul J. Mitchell

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard F. Pops

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alexander Rich

 

For

 

Yes

 

For

 

Management

1

 

Elect director Mark B. Skaletsky

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael A. Wall

 

For

 

Yes

 

For

 

Management

2

 

To ratify PricewaterhouseCoopers LLP as the company’s independent registered public accountant for fiscal year 2010

 

For

 

Yes

 

For

 

Management

 

4


 

02043Q107

 

ALNY

Alnylam Pharmaceuticals, Inc.

 

 

Meeting Date:

6/2/2010

 

Meeting Type:

Annual

Record Date:

4/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Victor J. Dzau, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kevin P. Starr

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to Alnylam’s 2004 employee stock purchase plan, as amended

 

For

 

Yes

 

Against

 

Management

3

 

To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam’s independent auditors for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

00163U106

 

AMAG

Amag Pharmaceuticals, Inc.

 

 

Meeting Date:

5/25/2010

 

Meeting Type:

Annual

Record Date:

3/30/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Joseph V. Bonventre, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael Narachi

 

For

 

Yes

 

For

 

Management

1

 

Elect director Brian J.G. Pereira, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Brian Robert J. Perez

 

For

 

Yes

 

For

 

Management

1

 

Elect director L. Russel, M.B., CH.B, MRCP

 

For

 

Yes

 

For

 

Management

1

 

Elect director Davey S. Scoon

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ron Zwanzinger

 

For

 

Yes

 

For

 

Management

2

 

Proposal to approve an amendment and restatement of our amended and restated 2007 equity incentive plan to, among other things, increase the number of shares of our common stock available for issuance thereunder by 800,000 shares

 

For

 

Yes

 

Against

 

Management

3

 

Proposal to approve our 2010 employee stock purchase plan

 

 

 

 

 

 

 

 

4

 

Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent auditor for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

5


 

031162100

 

AMGN

Amgen Inc.

 

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Dr. David Baltimore

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frank J. Biondi, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Francois de Carbonnel

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jerry D. Choate

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dr. Vance D. Coffman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frederick W. Gluck

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dr. Rebecca M. Henderson

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frank C. Herringer

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dr. Gilbert S. Omenn

 

For

 

Yes

 

For

 

Management

1

 

Elect director Judity C. Pelham

 

For

 

Yes

 

For

 

Management

1

 

Elect director Adm. J. paul Reason, UsN

 

For

 

Yes

 

For

 

Management

1

 

Elect director Leonard D. Schaeffer

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kevin W. Sharer

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

3A

 

Stockholder proposal #1 (Action by Written Consent)

 

Against

 

Yes

 

Against

 

Stockholder

3B

 

Stockholder proposal #2 (Equity retention policy)

 

Against

 

Yes

 

Against

 

Stockholder

 

032346108

 

AMLN

Amylin Pharmaceuticals, Inc.

 

 

Meeting Date:

4/29/2010

 

Meeting Type:

Annual

Record Date:

3/5/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Adrian Adams

 

For

 

Yes

 

For

 

Management

1

 

Elect director Teresa Beck

 

For

 

Yes

 

For

 

Management

1

 

Elect director M. Kathleen Behrens

 

For

 

Yes

 

For

 

Management

1

 

Elect director Daniel M. Bradbury

 

For

 

Yes

 

For

 

Management

1

 

Elect director Paul N. Clark

 

For

 

Yes

 

For

 

Management

1

 

Elect director Paulo F. Costa

 

For

 

Yes

 

For

 

Management

1

 

Elect director Karin Eastham

 

For

 

Yes

 

For

 

Management

1

 

Elect director James R. Gavin III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jay S. Skyler

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph P. Sullivan

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

6


 

04033A100

 

ARIA

Ariad Pharmaceuticals, Inc.

 

 

Meeting Date:

6/24/2010

 

Meeting Type:

Annual

Record Date:

4/28/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director A. Lavidas, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director M. Radaelli, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

The audit committee of the board of directors has selected Deloitte & Touche LLP to be our independent registered public accounting firm for the year ending December 31, 2010. The board of directors has ratified this selection.

 

For

 

Yes

 

For

 

Management

 

05365U101

 

AVTQY

Aveta Inc.

 

 

Meeting Date:

3/9/2010

 

Meeting Type:

Annual

Record Date:

2/16/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To elect Daniel E. Straus

 

For

 

Yes

 

For

 

Management

1

 

To elect Joseph D. Mark

 

For

 

Yes

 

For

 

Management

1

 

To elect Jonathan Kolatch

 

For

 

Yes

 

For

 

Management

 

09061G101

 

BMRN

Biomarin Pharmaceutical Inc.

 

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Jean-Jacques Bienaime

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael Grey

 

For

 

Yes

 

For

 

Management

1

 

Elect director Elaine J. Heron

 

For

 

Yes

 

For

 

Management

1

 

Elect director Pierre Lapalme

 

For

 

Yes

 

For

 

Management

1

 

Elect director V. Bryan Lawlis

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alan Lewis

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard A. Meier

 

For

 

Yes

 

For

 

Management

2

 

Vote to approve and reinstate the company’s 2006 incentive plan, as amended, to increase the number of shares by 8,000,000.

 

For

 

Yes

 

Against

 

Management

3

 

Ratification KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

14159L103

 

BEAT

CardioNet, Inc.

 

 

Meeting Date:

5/7/2010

 

Meeting Type:

Annual

Record Date:

3/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Eric N. Prystowsky, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect Rebecca W. Rimel

 

For

 

Yes

 

For

 

Management

1

 

Elect Robert J. Rubin, M.D.

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the Audit Committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

7


 

151020104

 

CELG

Celgene Corporation

 

 

Meeting Date:

6/16/2010

 

Meeting Type:

Annual

Record Date:

4/20/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Sol J. Barer, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Hugin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael D. Casey

 

For

 

Yes

 

For

 

Management

1

 

Elect director Carrie S. Cox

 

For

 

Yes

 

For

 

Management

1

 

Elect director Rodman L. Drake

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gilla Kaplan, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director James J. Loughlin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ernest Mario, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Walter L. Robb, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

156708109

 

CEPH

Cephalon, Inc.

 

 

Meeting Date:

5/20/2010

 

Meeting Type:

Annual

Record Date:

3/25/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director F. Baldino, Jr., Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director William P. Egan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Martyn D. Greenacre

 

For

 

Yes

 

For

 

Management

1

 

Elect director Vaughn M. Kailian

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kevin E. Moley

 

For

 

Yes

 

For

 

Management

1

 

Elect director C.A. Sanders, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gail R. Wilensky, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dennis L. Winger

 

For

 

Yes

 

For

 

Management

2

 

Approval of amendment to the 2004 equity compensation plan increasing the number of shares authorized for issuance

 

For

 

Yes

 

For

 

Management

3

 

Approval of Cephalon, Inc.’s 2010 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

4

 

Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

8


 

18725U109

 

CLDA

Clinical Data, Inc.

 

 

Meeting Date:

9/17/2009

 

Meeting Type:

Annual

Record Date:

7/22/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Andrew J. Fromkin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Larry D. Horner

 

For

 

Yes

 

For

 

Management

1

 

Elect director Randal J. Kirk

 

For

 

Yes

 

For

 

Management

1

 

Elect director Arthur B. Malman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Burton E. Sobel, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Scott L. Tarriff

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard J. Wallace

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Deloitte & Touche LLP to be our independent registered public accounting firm for the 2010 fiscal year

 

For

 

Yes

 

For

 

Management

 

N/A N/A

Concentric Medical, Inc.

 

 

Action by Written Consent:

9/30/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of 2009 Equity Incentive Plan

 

For

 

Yes

 

For

 

Management

 

21924P103

 

CRTX

Cornerstone Therapeutics Inc.

 

 

Meeting Date:

7/27/2009

 

Meeting Type:

Special

Record Date:

6/25/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the issuance and sale of shares of Cornerstone’s common stock to Chiesi Farmaceutici Spa pursuant to the stock purchase agreement, dated as of May 6, 2009, between Cornerston and Chiesi Framaceutici Spa, in an aggregate amount to be determined in accordance with the stock purchase agreement, presently estimated to be approximately 12,170,132 shares

 

For

 

Yes

 

For

 

Management

2

 

To adjourn the special meeting, if necessary to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the issuance of shares of Cornerstone’s common stock to Chiesi Framaceutici Spa pursuant to the stock purchase agreement, dated as of May 6, 2009, between Cornerstone and Chiesi Farmaceutica Spa

 

For

 

Yes

 

For

 

Management

 

9


 

21924P103

 

CRTX

Cornerstone Therapeutics Inc.

 

 

Meeting Date:

8/27/2009

 

Meeting Type:

Special

Record Date:

7/30/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To eliminate a provision requiring that any amendment of bylaws that is effected by shareholders be approved by the affirmative vote of at least 75% of the votes that can be cast

 

For

 

Yes

 

Against

 

Management

Management

1

 

To eliminate the requirement that any amendment to article sixth (relating to bylaws) be approved by the affirmative vote of at least 75% of the votes that can be cast

 

For

 

Yes

 

Against

 

Management

2

 

Eliminate the classified status of board so that all directors will be subject to reelection at each annual meeting

 

For

 

Yes

 

Against

 

Management

2

 

Add a provision to the effect that there will be two classes of directors, all as more fully described in the proxy statement

 

For

 

Yes

 

Against

 

Management

2

 

To eliminate provisions relating to quorum, action, removal of directors, vacancies of directors, stockholder nominations

 

For

 

Yes

 

Against

 

Management

2

 

To add provisions requiring the approval of Chiesi Farmaceutici Spa (when it owns 40% + of our stock) for certain types of corporate transactions

 

For

 

Yes

 

Against

 

Management

2

 

To eliminate the requirement that any amendment to article ninth (relating to management of Cornerstone) be approved by the affirmative vote of 75% of the votes that can be cast

 

For

 

Yes

 

Against

 

Management

3

 

To eliminate a prohibition against action by written consent of Cornerstone’s stockholders in lieu of a meeting

 

For

 

Yes

 

Against

 

Management

3

 

To eliminate the requirement that any amendment to article tenth (relating to action by written consent of stockholders) be approved by the affirmative vote of 75% of the votes that can be cast

 

For

 

Yes

 

Against

 

Management

4

 

To permit Chiesi (when it owns 50%+ of our stock) and its affiliates to engage in the same or similar business activities or lines of business as Cornerstone

 

For

 

Yes

 

For

 

Management

4

 

To establish procedures for allocation certain corporate opportunities between Cornerstone and Chiesi (when it owns 50%+ of our stock)

 

For

 

Yes

 

Against

 

Management

5

 

To eliminate a provision that only board of directors, chairman or chief executive officer may call a special meeting

 

For

 

Yes

 

Against

 

Management

5

 

Eliminate the requirement that any amendment to article eleventh be approved by the affirmative vote of 75% of the votes that can be cast

 

For

 

Yes

 

Against

 

Management

6

 

Approve an amendment to Cornerstone’s certificate of incorporation to add a new article eleventh to elect not to be subject to section 201 of the DGCL, an anti-takeover provision

 

For

 

Yes

 

Against

 

Management

7

 

Adjourn the special meeting, if necessary, to solicit additional proxies in favor of any of the proposals set fourth above

 

For

 

Yes

 

Against

 

Management

 

21924P103

 

CRTX

Cornerstone Therapeutics Inc.

 

 

Meeting Date:

5/20/2010

 

Meeting Type:

Annual

Record Date:

4/1/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Craig A. Collard

 

For

 

Yes

 

For

 

Management

1

 

Elect director Christophe Codeanne

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael Enright

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael Heffernan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alessandro Chiesi

 

For

 

Yes

 

For

 

Management

1

 

Elect director Anton Giorgio Failla

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert M. Stephan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Marco Vecchia

 

For

 

Yes

 

For

 

Management

2

 

To approve the company’s 2004 stock incentive plan, as amended and restated, to increase the number of shares authorized for issuance thereunder

 

For

 

Yes

 

For

 

Management

3

 

To ratify the selection by the audit committee of Grant Thornton LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

10


 

229678107

 

CBST

Cubist Pharmaceuticals, Inc.

 

 

Meeting Date:

6/10/2010

 

Meeting Type:

Annual

Record Date:

4/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Michael Bonney

 

For

 

Yes

 

For

 

Management

1

 

Elect director Mark Corrigan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Sylvie Gregoire

 

For

 

Yes

 

For

 

Management

2

 

A proposal to amend our 2010 equity incentive plan

 

For

 

Yes

 

For

 

Management

3

 

A proposal to approve our performance-based management incentive plan

 

For

 

Yes

 

For

 

Management

4

 

A proposal to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

249908104

 

DEPO

Depomed, Inc.

 

 

Meeting Date:

5/20/2010

 

Meeting Type:

Annual

Record Date:

3/31/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Peter D. Staple

 

For

 

Yes

 

For

 

Management

1

 

Elect director G. Steven Burrill

 

For

 

Yes

 

For

 

Management

1

 

Elect director Karen A. Dawes

 

For

 

Yes

 

For

 

Management

1

 

Elect director Carl. A. Pelzel

 

For

 

Yes

 

For

 

Management

1

 

Elect director James A. Schoeneck

 

For

 

Yes

 

For

 

Management

1

 

Elect director Craig R. Smith, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Julian N. Stern

 

For

 

Yes

 

For

 

Management

1

 

Elect director David B. Zenoff, D.B.A

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the 2004 equity incentive plan to increase the number of shares of common stock issuable under the plan by 2,500,000 shares

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to the 2004 employee stock purchase plan to increase the number of shares of common stock issuable under the plan by 500,000 shares

 

For

 

Yes

 

For

 

Management

4

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010 December 31, 2010

 

For

 

Yes

 

For

 

Management

 

11


 

266605104

 

DRRX

Durect Corporation

 

 

Meeting Date:

6/23/2010

 

Meeting Type:

Annual

Record Date:

4/26/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Felix Theeuwes

 

For

 

Yes

 

For

 

Management

1

 

Elect director Simon X. Benito

 

For

 

Yes

 

For

 

Management

1

 

Elect director Terrence F. Blascke

 

For

 

Yes

 

For

 

Management

2

 

The amendment to our certificate of incorporation to increase the number of authorized shares of common stock from 110,000,000 to 200,000,000

 

For

 

Yes

 

For

 

Management

3

 

An amendment and restatement of the 2000 stock plan

 

For

 

Yes

 

For

 

Management

4

 

An amendment and restatement of the 2000 employee stock purchase plan, including an increase of 250,000 in the number of shares of the company’s common stock available for issuance thereunder

 

For

 

Yes

 

For

 

Management

5

 

The ratification of our appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year

 

For

 

Yes

 

For

 

Management

 

N/A N/A

Eleme Medical Inc.

 

 

Action by Written Consent:

12/18/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Note financing

 

For

 

Yes

 

For

 

Management

2

 

Wavier of right of first offer

 

For

 

Yes

 

For

 

Management

3

 

General authorization

 

For

 

Yes

 

For

 

Management

 

N/A N/A

Eleme Medical Inc.

 

 

Action by Written Consent:

6/4/2010

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Note financing

 

For

 

Yes

 

For

 

Management

2

 

Wavier of right of first offer

 

For

 

Yes

 

For

 

Management

3

 

General authorization

 

For

 

Yes

 

For

 

Management

 

N31010106

 

EURX

Eurand N V

 

 

Meeting Date:

6/9/2010

 

Meeting Type:

Annual

Record Date:

5/12/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To adopt the company’s annual accounts for the financial year 2009

 

For

 

Yes

 

For

 

Management

2

 

To review the company’s reservation and dividend policy and affirm that no dividends will be declared

 

For

 

Yes

 

For

 

Management

3

 

To grant a discharge to the directors in respect of their management during the financial year 2009

 

For

 

Yes

 

For

 

Management

4

 

To re-appoint Ernst & Young LLP as independent auditor for the financial year 2010

 

For

 

Yes

 

For

 

Management

5

 

To amend the company’s equity compensation plan to increase the number of shares issuable under the plan

 

For

 

Yes

 

For

 

Management

6

 

Authorization to the board for a period of 5 years from the date of AGM to issue or grant rights to acquire shares in capital

 

For

 

Yes

 

For

 

Management

7

 

To grant authorization to the board of directors for a period of 18 months from the date of the AGM to acquire as many shares in the capital of the company as is permitted by the law and the articles of association

 

For

 

Yes

 

For

 

Management

8

 

To approve the re-appointment of two non-executive directors ‘B’, Mr. Rolf Classon and Mr. Angelo Malahias, to the board of directors for a term of four years

 

For

 

Yes

 

For

 

Management

9

 

To approve the non-executive director stock option grants for 2010

 

For

 

Yes

 

For

 

Management

10

 

To approve the non-executive director compensation for 2010

 

For

 

Yes

 

For

 

Management

11

 

To approve any other resolution tabled in connection with the above

 

For

 

Yes

 

For

 

Management

 

N/A N/A

FlowCardia Inc.

 

 

Action by Written Consent:

3/26/2010

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of amendment to fifth amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

General authority and ratification

 

For

 

Yes

 

For

 

Management

 

12


 

345838106

 

FRX

Forest Laboratories, Inc.

 

 

Meeting Date:

8/10/2009

 

Meeting Type:

Annual

Record Date:

6/19/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Howard Solomon

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lawrence S. Olanoff, MD, Phd

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nesli Basgoz, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director William J. Candee, III

 

For

 

Yes

 

For

 

Management

1

 

Elect director George S. Cohen

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dan L. Goldwasser

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kenneth E. Goodman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lester B. Salans, MD

 

For

 

Yes

 

For

 

Management

2

 

Approval of the company’s executive compensation philosophy, policies and procedures as described in the “Compensation Discussion and Analysis”

 

For

 

Yes

 

For

 

Management

3

 

Ratification of the selection of BDO Seidman, LLP as independent registered public accounting firm for the fiscal year ending March 31, 2010.

 

For

 

Yes

 

For

 

Management

 

36866T103

 

GPRO

Gen-Probe

 

 

Meeting Date:

5/13/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Carl W. Hull

 

For

 

Yes

 

For

 

Management

1

 

Elect director Armin M. Kessler

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lucy Shapiro, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as independent auditors of Gen-Probe incorporated for the fiscal year ending December 31,2 010

 

For

 

Yes

 

For

 

Management

3

 

To ratify the board of directors’ election of Brian A. McNamee to the board directors of Gen-Probe

 

For

 

Yes

 

For

 

Management

 

13


 

372917104

 

GENZ

Genzyme Corporation

 

 

Meeting Date:

6/16/2010

 

Meeting Type:

Contested-Annual

Record Date:

4/9/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Douglas A. Berthiaume

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Bertolini

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gail K. Boudreaux

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Carpenter

 

For

 

Yes

 

For

 

Management

1

 

Elect director Charles L. Cooney

 

For

 

Yes

 

For

 

Management

1

 

Elect director Victor J. Dzau

 

For

 

Yes

 

For

 

Management

1

 

Elect director Senator Connie Mack III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard F. Syron

 

For

 

Yes

 

For

 

Management

1

 

Elect director Henri A. Termeer

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ralph V. Witworth

 

For

 

Yes

 

For

 

Management

2

 

A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,750,000 shares

 

For

 

Yes

 

For

 

Management

3

 

A proposal to approve the 2009 employee stock purchase plan to increase the number of shares of common stock available for issuance under the plan by 1,500,000

 

For

 

Yes

 

For

 

Management

4

 

A proposal to amend the 2007 directors equity plan to increase the number of shares of common stock available for issuance under the plan by 250,000 shares

 

For

 

Yes

 

For

 

Management

5

 

A proposal to amend the restated articles of organization to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 90% to 40%

 

For

 

Yes

 

For

 

Management

6

 

A proposal to ratify the audit committee’s selection of independent auditors for 2010 (PricewaterhouseCoopers LLP)

 

For

 

Yes

 

For

 

Management

 

372917104

 

GENZ

Genzyme Corporation

 

 

Meeting Date:

6/16/2010

 

Meeting Type:

Contested-Annual

Record Date:

4/9/2010

 

 

 

 

#

 

Proposal

 

Opposition Rec.

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Dr. Steven Burakoff

 

For

 

No

 

None

 

Opposition

1

 

Elect director Dr. Alexander J. Denner

 

For

 

No

 

None

 

Opposition

1

 

Elect director Carl C. Icahn

 

For

 

No

 

None

 

Opposition

1

 

Elect director Dr. Richard Mulligam

 

For

 

No

 

None

 

Opposition

1

 

Elect director Douglas A. Berthiaume

 

For

 

No

 

None

 

Opposition

1

 

Elect director Robert J. Bertolini

 

For

 

No

 

None

 

Opposition

1

 

Elect director Gail K. Boudreaux

 

For

 

No

 

None

 

Opposition

1

 

Elect director Robert J. Carpenter

 

For

 

No

 

None

 

Opposition

1

 

Elect director Victor J. Dzau

 

For

 

No

 

None

 

Opposition

1

 

Elect director Ralph V. Witworth

 

For

 

No

 

None

 

Opposition

2

 

A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,750,000 shares

 

For

 

No

 

None

 

Management

3

 

A proposal to approve the 2009 employee stock purchase plan to increase the number of shares of common stock available for issuance under the plan by 1,500,000

 

For

 

No

 

None

 

Opposition

4

 

A proposal to amend the 2007 directors equity plan to increase the number of shares of common stock available for issuance under the plan by 250,000 shares

 

For

 

No

 

None

 

Management

5

 

A proposal to amend the restated articles of organization to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 90% to 40%

 

For

 

No

 

None

 

Management

6

 

A proposal to ratify the audit committee’s selection of independent auditors for 2010 (PricewaterhouseCoopers LLP)

 

For

 

No

 

None

 

Management

 

14


 

375558103

 

GILD

Gilead Sciences, Inc.

 

 

Meeting Date:

5/11/2010

 

Meeting Type:

Annual

Record Date:

3/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Paul Berg

 

For

 

Yes

 

For

 

Management

1

 

Elect director John F. Cogan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Etienne F. Davignon

 

For

 

Yes

 

For

 

Management

1

 

Elect director James M. Denny

 

For

 

Yes

 

For

 

Management

1

 

Elect director Carla A. Hills

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kevin E. Lofton

 

For

 

Yes

 

For

 

Management

1

 

Elect director John W. Madigan

 

For

 

Yes

 

For

 

Management

1

 

Elect director John C. Martin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gordon E. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nicholas G. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard J. Whitley

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gayle E. Wilson

 

For

 

Yes

 

For

 

Management

1

 

Elect director Per Wold-Olsen

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

3

 

If properly presented at the meeting, to vote on a stockholder proposal requesting that the board take steps to adopt majority voting standards in Gilead’s certificate of incorporation and by-laws

 

Against

 

Yes

 

Against

 

Stockholder

 

15


 

436440101

 

HOLX

Hologic, Inc.

 

 

Meeting Date:

3/3/2010

 

Meeting Type:

Annual

Record Date:

1/8/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director John W. Cumming

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert A. Cascella

 

For

 

Yes

 

For

 

Management

1

 

Elect director Sally W. Crawford

 

For

 

Yes

 

For

 

Management

1

 

Elect director David R. Lavance, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nancy L. Leaming

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lawrence M. Levy

 

For

 

Yes

 

For

 

Management

1

 

Elect director Glenn P. Muir

 

For

 

Yes

 

For

 

Management

1

 

Elect director Elaine S. Ullian

 

For

 

Yes

 

For

 

Management

1

 

Elect director Wayne Wilson

 

For

 

Yes

 

For

 

Management

2

 

To consider and act upon ratification of the appointment of Ernst & Young LLP as Hologic’s independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

3

 

To consider and act upon the adjournment of the annual meeting

 

For

 

Yes

 

For

 

Management

 

45103T107

 

ICLR

Icon plc

 

 

Meeting Date:

7/20/2009

 

Meeting Type:

Annual

Record Date:

6/10/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To receive the accounts and reports

 

For

 

Yes

 

For

 

Management

2

 

To re-elect Dr. Ronan Lambe

 

For

 

Yes

 

For

 

Management

3

 

To re-elect Dr. Peter Gray

 

For

 

Yes

 

For

 

Management

4

 

To re-elect Dr. Anthony Murphy

 

For

 

Yes

 

For

 

Management

5

 

To authorize the fixing of the auditor’s renumeration

 

For

 

Yes

 

For

 

Management

6

 

To authorize the company to allot shares

 

For

 

Yes

 

For

 

Management

7

 

To display the statutory pre-emption rights

 

For

 

Yes

 

For

 

Management

8

 

To authorize the company to make market purchases of shares

 

For

 

Yes

 

For

 

Management

 

16


 

45168D104

 

IDXX

IDEXX Laboratories, Inc.

 

 

Meeting Date:

5/5/2010

 

Meeting Type:

Annual

Record Date:

3/8/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Jonathan W. Ayers

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Murray

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph V. Vumbacco

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of the board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year

 

For

 

Yes

 

For

 

Management

 

452327109

 

ILMN

Illumina, Inc.

 

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Paul C. Grint, M.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director David R. Walt, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Ratify the appointment of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending January 2, 2011

 

For

 

Yes

 

For

 

Management

 

46120E602

 

ISRG

Intuitive Surgical, Inc.

 

 

Meeting Date:

4/21/2010

 

Meeting Type:

Annual

Record Date:

2/22/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Alan J. Levy

 

Yes

 

For

 

Yes

 

Management

 

1

 

Elect director Eric H. Halvorson

 

Yes

 

For

 

Yes

 

Management

 

1

 

Elect director Amal M. Johnson

 

Yes

 

For

 

Yes

 

Management

 

2

 

To approve the company’s 2010 incentive award plan

 

Yes

 

For

 

Yes

 

Management

 

 

464330109

 

ISIS

ISIS Pharmaceuticals, Inc.

 

 

Meeting Date:

6/2/2010

 

Meeting Type:

Annual

Record Date:

4/6/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Stanley T. Crooke

 

Yes

 

For

 

Yes

 

Management

 

1

 

Elect director Joseph Klein, III

 

Yes

 

For

 

Yes

 

Management

 

1

 

Elect director John C. Reed

 

Yes

 

For

 

Yes

 

Management

 

2

 

To approve an amendment to the 2002 non-employee directors’ stock option plan to increase the shares authorized for issuance under the plan from 850,000 shares to 1,000,000 shares and to extend the term from May 30, 2012 to June 1, 2020

 

Yes

 

For

 

Yes

 

Management

 

3

 

To approve an amendment to the 1989 stock option plan to increase the shares authorized for issuance under the plan from 16,700,000 shares to 20,000,000 shares

 

 

 

 

 

 

 

 

 

4

 

To ratify the audit committee’s selection of Ernst & Young LLP as independent auditors for our 2010 fiscal year

 

Yes

 

For

 

Yes

 

Management

 

 

N/A N/A

Labcyte Inc.

 

 

Action by Written Consent:

10/1/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Approval of the loan agreement

 

For

 

Yes

 

For

 

Management

 

2

 

Approval of issuance of the warrant

 

For

 

Yes

 

For

 

Management

 

3

 

Approval of waiver of right of first offer

 

For

 

Yes

 

For

 

Management

 

4

 

Omnibus resolution

 

For

 

Yes

 

For

 

Management

 

 

17


 

50540R409

 

LH

Laboratory Corp. of America Holdings

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Thomas P. MacMahon

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Kerrii B. Anderson

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Jean-Luc Belingard

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director David P. King

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Wendy E. Lane

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Robert E. Mittelstaedt, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Arthur H. Rubenstein, Mbbch

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director M. Keith Weikel, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director R. Sanders Williams, MD

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2010

 

For

 

Yes

 

For

 

Management

 

 

528872104

 

LXRX

Lexicon Pharmaceuticals, Inc.

 

Meeting Date:

7/15/2009

 

Meeting Type:

Special

Record Date:

5/21/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Approval of an amendment to the company’s certificate of incorporation increasing the number of authorized shares of the company’s common stock from 300,000,000 to 900,000,000

 

For

 

Yes

 

Against

 

Management

 

 

18


 

53217V109

 

LIFE

Life Technologies Corporation

 

Meeting Date:

4/29/2010

 

Meeting Type:

Annual

Record Date:

3/1/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director George F. Adam, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Raymond V. Dittamore

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Arnold J. Levine, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Per A. Peterson, Ph.D. Bradley G. Lorimier

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director David D. U’Prichard, Ph.D.

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of Ernst & Young LLP as independent auditors of the company for fiscal year 2010

 

For

 

Yes

 

For

 

Management

 

3

 

Adoption of an amendment to the restated certificate of incorporation of the company (adopt majority voting for uncontested elections of directors)

 

For

 

Yes

 

Against

 

Management

 

4

 

Adoption of amendments to the restated certificate of incorporation of the company (eliminate supermajority provisions)

 

For

 

Yes

 

For

 

Management

 

5

 

Adoption of amendments to the bylaws of the company (adopt majority voting for uncontested elections of directors)

 

For

 

Yes

 

Against

 

Management

 

6

 

Adoption of an amendment to the bylaws of the company (eliminate supermajority provisions)

 

For

 

Yes

 

Against

 

Management

 

7

 

Adoption of the company’s 2010 incentive compensation plan

 

For

 

Yes

 

Against

 

Management

 

 

572901106

 

MATK

Martek Biosciences Corporation

 

Meeting Date:

3/18/2010

 

Meeting Type:

Annual

Record Date:

1/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Harry J. D’Andrea

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director James R. Beery

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Michael G. Devine

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Steve Dubin

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Robert J. Flanagan

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Polly B. Kawalek

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Jerome C. Keller

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Douglas J. Macmaster, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Robert H. Mayer

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director David M. Pernock

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Eugene H. Rotberg

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year 2010

 

For

 

Yes

 

For

 

Management

 

 

19


 

628530107

 

MYL

Mylan, Inc.

 

Meeting Date:

5/14/2010

 

Meeting Type:

Annual

Record Date:

3/25/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Mark W. Parrish

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Robert J. Coury

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Wendy Cameron

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Neil Dimick, CPA

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Doug Leech, CPA

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Joseph C. Maroon, MD

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Rodney L. Piatt, CPA

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director C.B. Todd

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director R.L. Vanderveen, Ph.D. R.Ph.

 

For

 

Yes

 

For

 

Management

 

2

 

Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

3

 

Shareholder proposal-advisory (non-binding) vote on executive compensation

 

Against

 

Yes

 

For

 

Stockholder

 

4

 

Shareholder proposal- retention of executive equity compensation

 

Against

 

Yes

 

Against

 

Stockholder

 

 

62855J104

 

MYGN

Myriad Genetics, Inc.

 

Meeting Date:

11/5/2009

 

Meeting Type:

Annual

Record Date:

9/15/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director John T. Henderson, MD

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director S. Louise Phanstiel

 

For

 

Yes

 

For

 

Management

 

2

 

Proposal to amend the 2003 employee, director and consultant stock option plan to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares

 

For

 

Yes

 

For

 

Management

 

3

 

Proposal to ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending June 30, 2010

 

For

 

Yes

 

For

 

Management

 

 

N/A N/A

Palyon Medical Corporation

 

Action by Written Consent:

8/26/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Authorization of amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

 

 

N/A N/A

Palyon Medical Corporation

 

 

Action by Written Consent:

5/10/2010

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Board of directors appointments and designations

 

For

 

Yes

 

For

 

Management

 

 

709754105

 

PPCO

Penwest Pharmaceuticals Co.

 

Meeting Date:

6/22/2010

 

Meeting Type:

Annual- Contested

Record Date:

4/30/2010

 

 

 

 

#

 

Proposal

 

Opposition Rec.

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Roderick Wong M.D.

 

For

 

Yes

 

For

 

Opposition

 

1

 

Elect director Saiid Zarrabian

 

For

 

Yes

 

For

 

Opposition

 

1

 

Elect director John G. Lemkey

 

For

 

Withheld

 

None

 

Opposition

 

2

 

Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Opposition

 

 

20


 

709754105

 

PPCO

Penwest Pharmaceuticals Co.

 

Meeting Date:

6/22/2010

 

Meeting Type:

Annual - Contested

Record Date:

4/30/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Christopher M. Bianchi

 

For

 

No

 

None

 

Management

 

1

 

Elect director Paul E. Freidman

 

For

 

No

 

None

 

Management

 

1

 

Elect director Jennifer L. Good

 

For

 

No

 

None

 

Management

 

2

 

Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year ending December 31, 2010

 

For

 

No

 

None

 

Management

 

 

714290103

 

PRGO

Perrigo Company

 

Meeting Date:

10/29/2009

 

Meeting Type:

Annual

Record Date:

9/4/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Gary M. Cohen

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director David T. Gibbons

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ran Gottfried

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ellen R. Hoffing

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of Ernst & Young LLP as the independent Public Accountants of the company for the fiscal year 2010

 

For

 

Yes

 

For

 

Management

 

 

717124101

 

PPDI

Pharmaceutical Product Development, Inc.

 

Meeting Date:

5/20/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Stuart Bondurant, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Frederic N. Eshelman

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Frederick Frank

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director General David L. Grange

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Catherine M. Klema

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Terry Magnuson, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ernest Mario, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director John A. McNeill, Jr.

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

4

 

In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting

 

For

 

Yes

 

For

 

Management

 

 

21


 

75886F107

 

REGN

Regeneron Pharmaceuticals, Inc.

 

Meeting Date:

6/11/2010

 

Meeting Type:

Annual

Record Date:

4/14/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Leonard S. Schleifer

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Eric M. Shooter

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director George D. Yancopoulos

 

For

 

Yes

 

For

 

Management

 

2

 

Proposal to ratify the appointment of PriceWaterHouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

82481R106

 

SHPGY

Shire Plc

 

Meeting Date:

4/27/2010

 

Meeting Type:

Annual

Record Date:

3/23/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

To receive the company’s accounts for the year ended December 31, 2009

 

For

 

Yes

 

For

 

Management

 

2

 

To approve the directors’ remuneration report for the year ended December 31, 2009

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Mr. David Stout

 

For

 

Yes

 

For

 

Management

 

4

 

Elect director Mr. William Burns

 

For

 

Yes

 

For

 

Management

 

5

 

To re-appoint Deloite LLP as auditors of the company to hold office from the conclusion of the meeting to the conclusion of the annual general meeting of the company to be held in 2011

 

For

 

Yes

 

For

 

Management

 

6

 

To authorize the audit, compliance & risk committee of the board to determine the remuneration of the auditors

 

For

 

Yes

 

For

 

Management

 

7

 

To resolve that the authority to allot relevant securities (as defined in the company’s articles of association) conferred on the directors by article 10 paragraph (B) of the company’s articles of association be renewed and for this purpose the authorized allotment amount

 

For

 

Yes

 

For

 

Management

 

8

 

To approve the proposed amendments (summarized in the explanatory notes to this notice) to the Shire portfolio share plan and to authorize the directors to do all such things as may be necessary to carry the same into effect

 

For

 

Yes

 

For

 

Management

 

9

 

To resolve that, subject to the passing of the previous resolution, the authority to allot equity securities (as defined in the company’s articles of association) wholly for cash, conferred on the directors by article 10 paragraph (D) of the company’s articles of association be renewed, all as more fully described in the proxy statement

 

For

 

Yes

 

For

 

Management

 

10

 

To resolve that the company be and is hereby generally and unconditionally authorized: (A) pursuant to article 57 of the Companies (Jersey) Law 1991 to make market purchase of ordinary shares in the capital of the company (B) pursuant to article 58A of the Companies (Jersey) Law 1991, to hold as treasury shares any ordinary shares purchased pursuant to the authority conferred by paragraph (A) of this resolution

 

For

 

Yes

 

For

 

Management

 

 

22


 

834453102

 

SOMX

Somaxon Pharmaceuticals

 

Meeting Date:

6/9/2010

 

Meeting Type:

Annual

Record Date:

4/15/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Richard W. Pacoe

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Kurt Von Emster

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the selection of PriceWaterHouseCoopers LLP as Somaxon’s independent registered public accounting firm for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

863667101

 

SYK

Stryker Corporation

 

Meeting Date:

4/27/2010

 

Meeting Type:

Annual

Record Date:

3/1/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Howard E. Cox, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Srikant M. Datar

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Donald M. Engelman

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Louise L. Francesconi

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Howard L. Lance

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Stephen P. Macmillan

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director William U. Parfet

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ronda E. Stryker

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2010

 

For

 

Yes

 

For

 

Management

 

 

N/A N/A

TargeGen Inc.

 

 

Action by Written Consent:

11/25/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Approval of amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

 

2

 

Approval of amendments to amended and restated investor rights agreement and amended and restated right of the first refusal and co-sale agreement

 

For

 

Yes

 

For

 

Management

 

3

 

General authority

 

For

 

Yes

 

For

 

Management

 

 

N/A N/A

TargeGen Inc.

 

 

Action by Written Consent:

6/25/2010

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Approval of amendment to merger agreement

 

For

 

Yes

 

For

 

Management

 

3

 

General authority

 

For

 

Yes

 

For

 

Management

 

 

87959M109

 

TELK

Telik, Inc.

 

Meeting Date:

5/12/2010

 

Meeting Type:

Annual

Record Date:

3/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Michael M. Wick, M.D., Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Richard B. Newman, Esq.

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of the company by the audit committee of the board of directors of the company for its fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

23


 

881624209

 

TEVA

Teva Pharmaceutical Industries Ltd.

 

Meeting Date:

6/29/2010

 

Meeting Type:

Annual

Record Date:

5/24/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

To approve the board of directors’ recommendation that the cash dividend for year ended December 31, 2009, which was paid in four installments and aggregated NIS 2.50 (approximately $0.642, according to the applicable exchange rates) per ordinary share (or ADS), be declared final

 

For

 

Yes

 

For

 

Management

 

2

 

Elect director Mr. Abraham E. Cohen

 

For

 

Yes

 

For

 

Management

 

2

 

Elect director Mr. Amir Elstein

 

For

 

Yes

 

For

 

Management

 

2

 

Elect director Prof. Elon Kohlberg

 

For

 

Yes

 

For

 

Management

 

2

 

Elect director Prof. Moshe Many

 

For

 

Yes

 

For

 

Management

 

2

 

Elect director Mr. Dan Propper

 

For

 

Yes

 

For

 

Management

 

3

 

To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as the company’s independent registered public accounting firm until the 2011 annual meeting of shareholders and to authorize the board of directors to determine their compensation provided such compensation is also approved by the audit committee

 

For

 

Yes

 

For

 

Management

 

4

 

To approve the company’s 2010 long-term equity-based incentive plan

 

For

 

Yes

 

For

 

Management

 

5

 

Approve remuneration of Dr. Phillip Frost, in his capacity as chairman of the board, effective as of March 9, 2010, in the amount of nis equivalent of of USD 385,702 (as of March 9, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors), provision to Dr. Frost, in his capacity as chairman of the board, of an office and secretarial services, and, effective as of February 15, 2010, all as more fully, described in the proxy statement

 

For

 

Yes

 

For

 

Management

 

5

 

Approve remuneration of Prof. Moshe Many, in his capacity as vice chairman of the board, effective as of March 9, 2010, in the amount of nis equivalent of of USD 150,000 (as of March 9, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors), provision to Prof. Many, in his capacity as vice chairman of the board, of an office and secretarial services

 

For

 

Yes

 

For

 

Management

 

5

 

Approve remuneration of Prof. Roger Kornberg, in his capacity as a director of Teva, effective as of March 10, 2010, in the amount of nis equivalent of of USD 150,000 (as of March 10, 2010) per annum, plus vat (as applicable), as adjusted by the Israeli consumer price index (in addition to per meeting fees paid to directors)

 

For

 

Yes

 

For

 

Management

 

6

 

To approve an increase in the registered share capital of the company by nis 100,000,000 to a total of nis 250,000,000 by the creation of 1,000,000,000 additional ordinary shares of par value nis 0.1 each, and the amendment of the company’s incorporation documents accordingly

 

For

 

Yes

 

For

 

Management

 

 

24


 

91307C102

 

UTHR

United Therapeutics Corporation

 

Meeting Date:

6/28/2010

 

Meeting Type:

Annual

Record Date:

4/29/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Christopher Causey

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Richard Giltner

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director R. Paul Gray

 

For

 

Yes

 

For

 

Management

 

2

 

Approval of the amendment to the amended and restated certificate of incorporation to increase authorized number of shares of common stock

 

For

 

Yes

 

For

 

Management

 

3

 

Vote to ratify Ernst & Young LLP as United Therapeutics Corporation’s independent registered public accounting firm for 2010

 

For

 

Yes

 

For

 

Management

 

 

918194101

 

WOOF

VCA Antech, Inc.

 

Meeting Date:

6/14/2010

 

Meeting Type:

Annual

Record Date:

4/19/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Robert L. Antin

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

92532F100

 

VRTX

Vertex Pharmaceuticals Incorporated

 

Meeting Date:

5/13/2010

 

Meeting Type:

Annual

Record Date:

3/17/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect Director Joshua Boger

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Joshua Boger Charles A. Sanders

 

For

 

Yes

 

For

 

Management

 

1

 

Elect Director Elaine S. Ullian

 

For

 

Yes

 

For

 

Management

 

2

 

Approval of the amendment to the amended and restated 2006 stock and option plan the number of shares of common stock by 12,000,000.

 

For

 

Yes

 

Against

 

Management

 

3

 

Vote to ratify Ernst & young LLP as Vertex Pharmaceutical’s registered public accounting firm for the year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

25


 

G94368100

 

WCRX

Warner Chilcott Public Limited Company

 

Meeting Date:

5/13/2010

 

Meeting Type:

Annual

Record Date:

3/16/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1A

 

Elect Director John O. Connaughton

 

For

 

Yes

 

For

 

Management

 

1B

 

Elect Director Stephen P. Murray

 

For

 

Yes

 

For

 

Management

 

2

 

Vote to ratify PricewaterhouseCoopers LLP as Warner Chilcott’s independent registered public accounting firm for 2010

 

For

 

Yes

 

For

 

Management

 

 

94973V107

 

WLP

WellPoint, Inc.

 

Meeting Date:

5/18/2010

 

Meeting Type:

Annual

Record Date:

3/17/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Sheila P. Burke

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director George A. Schaffer, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Jackie M. Ward

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for 2010

 

For

 

Yes

 

For

 

Management

 

3

 

If properly presented at the meeting, to vote on a shareholder proposal concerning a feasibility study for converting to nonprofit status

 

Against

 

Yes

 

Against

 

Stockholder

 

4

 

If properly presented at the meeting, to vote on a shareholder proposal concerning disclosure of lobbying expenses

 

Against

 

Yes

 

For

 

Stockholder

 

5

 

If properly presented at the meeting, to vote on a shareholder proposal concerning an advisory resolution on compensation of named executive officers

 

Against

 

Yes

 

For

 

Stockholder

 

6

 

If properly presented at the meeting, to vote on a shareholder proposal to change our jurisdiction of incorporation from Indiana to Delaware

 

Against

 

Yes

 

Against

 

Stockholder

 

 

26


 

983024100

 

WYE

Wyeth

 

Meeting Date:

7/20/2009

 

Meeting Type:

Annual

Record Date:

6/5/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Vote to adopt the agreement and plan of merger, dated as of January 25, 2009 by and among Pfizer, Inc., Wagner Acquisition Corp. and Wyeth, as it may be amended from time to time.

 

For

 

Yes

 

For

 

Management

 

2

 

Vote to approve the adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes to adopt the merger agreement

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Robert M. Amen

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Michael J. Critelli

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Frances D. Ferguson

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Victor F. Ganzi

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Robert Langer

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director John P. Mascotte

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Raymond J. McGuire

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Mary Lake Polan

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Bernard Poussot

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director Gary L. Rogers

 

For

 

Yes

 

For

 

Management

 

3

 

Elect director John r. Torell III

 

For

 

Yes

 

For

 

Management

 

4

 

Vote to ratify PricewaterhouseCoopers LLP as Wyeth’s independent registered public accounting firm for 2009

 

For

 

Yes

 

For

 

Management

 

5

 

Stockholder proposal regarding reporting on Wyeth’s political contributions and trade association payments

 

Against

 

Yes

 

Against

 

Stockholder

 

6

 

Stockholder proposal regarding special stockholder meetings

 

Against

 

Yes

 

Against

 

Stockholder

 

 

98411C100

 

XNPT

Xenoport, Inc.

 

Meeting Date:

5/11/2010

 

Meeting Type:

Annual

Record Date:

3/24/2010

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Paul L. Berns

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director John G. Freund, M.D.

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the selection by the Audit Committee of the board of directors of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2010

 

For

 

Yes

 

For

 

Management

 

 

27


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

 

 

(Daniel R. Omstead, President)

 

/s/ Daniel R. Omstead

 

Date

8/31/10

 

*Print the name and title of each signing officer under his or her signature.

 

2